Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

1.

Cost of care for malignant and benign renal masses.

Asnis-Alibozek AG, Fine MJ, Russo P, McLaughlin T, Farrelly EM, LaFrance N, Lowrance W.

Am J Manag Care. 2013 Aug;19(8):617-24.

PMID:
24304211
[PubMed - indexed for MEDLINE]
Free Article
2.

Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.

Matthay KK, Weiss B, Villablanca JG, Maris JM, Yanik GA, Dubois SG, Stubbs J, Groshen S, Tsao-Wei D, Hawkins R, Jackson H, Goodarzian F, Daldrup-Link H, Panigrahy A, Towbin A, Shimada H, Barrett J, Lafrance N, Babich J.

J Nucl Med. 2012 Jul;53(7):1155-63. doi: 10.2967/jnumed.111.098624. Epub 2012 Jun 14.

PMID:
22700000
[PubMed - indexed for MEDLINE]
Free Article
3.

New pathways to medicare coverage for innovative PET radiopharmaceuticals: report of a medical imaging & technology alliance (MITA) workshop.

Hillman BJ, Frank RA, Rodriguez GM; Medical Imaging & Technology Alliance (MITA) Workshop participants.

J Nucl Med. 2012 Feb;53(2):336-42. doi: 10.2967/jnumed.111.098947. Epub 2011 Dec 16.

PMID:
22178626
[PubMed - indexed for MEDLINE]
Free Article
4.

Iodofiltic acid I 123 (BMIPP) fatty acid imaging improves initial diagnosis in emergency department patients with suspected acute coronary syndromes: a multicenter trial.

Kontos MC, Dilsizian V, Weiland F, DePuey G, Mahmarian JJ, Iskandrian AE, Bateman TM, Heller GV, Ananthasubramaniam K, Li Y, Goldman JL, Armor T, Kacena KA, LaFrance ND, Garcia EV, Babich JW, Udelson JE.

J Am Coll Cardiol. 2010 Jul 20;56(4):290-9. doi: 10.1016/j.jacc.2010.03.045.

PMID:
20633821
[PubMed - indexed for MEDLINE]
Free Article
5.

90Y-edotreotide for metastatic carcinoid refractory to octreotide.

Bushnell DL Jr, O'Dorisio TM, O'Dorisio MS, Menda Y, Hicks RJ, Van Cutsem E, Baulieu JL, Borson-Chazot F, Anthony L, Benson AB, Oberg K, Grossman AB, Connolly M, Bouterfa H, Li Y, Kacena KA, LaFrance N, Pauwels SA.

J Clin Oncol. 2010 Apr 1;28(10):1652-9. doi: 10.1200/JCO.2009.22.8585. Epub 2010 Mar 1.

PMID:
20194865
[PubMed - indexed for MEDLINE]
6.

Radiation dosimetry, pharmacokinetics, and safety of ultratrace Iobenguane I-131 in patients with malignant pheochromocytoma/paraganglioma or metastatic carcinoid.

Coleman RE, Stubbs JB, Barrett JA, de la Guardia M, Lafrance N, Babich JW.

Cancer Biother Radiopharm. 2009 Aug;24(4):469-75. doi: 10.1089/cbr.2008.0584.

PMID:
19694582
[PubMed - indexed for MEDLINE]
7.

Pharmacokinetics and safety of gadobenate dimeglumine (multihance) in subjects with impaired liver function.

Davies BE, Kirchin MA, Bensel K, Lorusso V, Davies A, Parker JR, Lafrance ND.

Invest Radiol. 2002 May;37(5):299-308.

PMID:
11979156
[PubMed - indexed for MEDLINE]
8.

Use of a decision-analytic model to support the use of a new oral US contrast agent in patients with abdominal pain.

Bree RL, Arnold RJ, Pettit KG, Kaniecki DJ, O'haeri C, LaFrance ND, Toaff AL.

Acad Radiol. 2001 Mar;8(3):234-42.

PMID:
11249087
[PubMed - indexed for MEDLINE]
9.

Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment.

Swan SK, Lambrecht LJ, Townsend R, Davies BE, McCloud S, Parker JR, Bensel K, LaFrance ND.

Invest Radiol. 1999 Jul;34(7):443-8.

PMID:
10399633
[PubMed - indexed for MEDLINE]
10.

Dynamic susceptibility contrast MR imaging for the evaluation of probable Alzheimer disease: a cost-effectiveness analysis.

LaFrance ND, Parker JR, Smith MD, McGhan WF, Renshaw PF, Harris GJ, Weaver M.

Acad Radiol. 1998 Apr;5 Suppl 1:S231-3; discussion S234-5. No abstract available.

PMID:
9561088
[PubMed - indexed for MEDLINE]
11.

Preliminary cost-effectiveness evaluation of an oral sonographic contrast agent using a decision modeling technique.

LaFrance ND, Brooks K, Yin D, Parker JR, Bensel K, Macchi D, Lev-Toaff AS.

Acad Radiol. 1996 Aug;3 Suppl 2:S426-31. No abstract available.

PMID:
8796621
[PubMed - indexed for MEDLINE]
12.

Development of an oral contrast agent for sonography: clinical and economic considerations.

LaFrance ND, Yin D, Brooks K, Lev-Toaff AS, Bensel KS, Meeks MJ, Macchi D.

Acad Radiol. 1996 Apr;3 Suppl 1:S160-1. No abstract available.

PMID:
8796551
[PubMed - indexed for MEDLINE]
13.

Bone mineral density of eating disorder subgroups.

Andersen AE, Woodward PJ, LaFrance N.

Int J Eat Disord. 1995 Dec;18(4):335-42.

PMID:
8580919
[PubMed - indexed for MEDLINE]
14.

Clinical experience with gadodiamide injection in magnetic resonance imaging of the central nervous system.

Andrew E, Svaland M, Lundby B, Hugo F, LaFrance N.

Invest Radiol. 1994 Jun;29 Suppl 2:S186-8. No abstract available.

PMID:
7928225
[PubMed - indexed for MEDLINE]
15.

Altered cortical blood flow in HIV-seropositive individuals with and without dementia: a single photon emission computed tomography study.

Harris GJ, Pearlson GD, McArthur JC, Zeger S, LaFrance ND.

AIDS. 1994 Apr;8(4):495-9.

PMID:
8011253
[PubMed - indexed for MEDLINE]
16.

Effect of magnetic susceptibility contrast medium on myocardial signal intensity with fast gradient-recalled echo and spin-echo MR imaging: initial experience in humans.

Sakuma H, O'Sullivan M, Lucas J, Wendland MF, Saeed M, Dulce MC, Watson A, Bleyl KL, LaFrance ND, Higgins CB.

Radiology. 1994 Jan;190(1):161-6.

PMID:
8259398
[PubMed - indexed for MEDLINE]
17.

Comparison of indium-111 antimyosin antibody and technetium-99m pyrophosphate localization in reperfused and nonreperfused myocardial infarction.

Takeda K, LaFrance ND, Weisman HF, Wagner HN Jr, Becker LC.

J Am Coll Cardiol. 1991 Feb;17(2):519-26.

PMID:
1846888
[PubMed - indexed for MEDLINE]
18.

Indium-111 myosin-specific antibodies and technetium-99m pyrophosphate in the detection of acute cardiac rejection of transplanted hearts: studies in a heterotopic rat heart model.

Takeda K, Ueda K, Scheffel U, Ravert H, LaFrance ND, Baumgartner WA, Reitz BA, Herskowitz A, Wagner HN Jr.

Eur J Nucl Med. 1991;18(7):461-6.

PMID:
1833199
[PubMed - indexed for MEDLINE]
19.

Diagnosis of Campylobacter pylori gastritis.

Mertz H, LaFrance N, Kafonek D, Yardley J, Hendrix T.

Dig Dis Sci. 1991 Jan;36(1):1-4.

PMID:
1984994
[PubMed - indexed for MEDLINE]
20.

Prevention of hypothyroidism related to mantle irradiation for Hodgkin's disease: preparative phantom study.

Marcial-Vega VA, Order SE, Lastner G, Cole PD, LaFrance N, O'Neill M.

Int J Radiat Oncol Biol Phys. 1990 Mar;18(3):613-8.

PMID:
2318694
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk